Cathay International Holdings Ltd (CTI) Common Shares USD0.01
CATHAY INTERNATIONAL HOLDINGS LIMITED is an investment holding company principally engaged in the healthcare business. The Company operates five business segments through its subsidiaries. The Lansen segment engages in the manufacture and sale of pharmaceuticals, cosmeceutical products and plant extracts and healthcare products. The Haizi segment produces inositol and its by-product, di-calcium phosphate. The Natural Dailyhealth segment is involved in the production and sales of plant extracts for use as active ingredients in health products. The Botai segment involves in the production and sales of collagen injectable fillers and development of collagen related products. The Hotel Operation segment operates a hotel.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.